GENEVA, Oct. 9 -- JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD. filed a patent application (CN2026/087943) for “CONJUGATE TARGETING PD-L1 AND INTEGRIN”. With publication no. WO/2026/208933, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....